Literature DB >> 21701822

Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas.

L G Sobrinho1, J S Duarte, I Paiva, L Gomes, V Vicente, P Aguiar.   

Abstract

It has been reported that women with prolactinoma were exposed, early in life, to an environment characterized by an absent or violent father. The present study was designed to evaluate whether paternal absence or violent paternal behavior were more prevalent in patients with pituitary adenomas (prolactinoma, acromegaly, non-secreting adenoma and Cushing's disease) compared to a control population. We conducted an observational case-control multicenter study. We interviewed 395 patients with prolactinoma (296 females and 99 males), 130 with acromegaly (87 females and 43 males), 237 with non-secreting adenoma (144 females and 93 males) and 68 with Cushing's disease (61 females and 7 males) and 365 patients from the same clinics with nodular thyroid disease or lymphocytic thyroiditis with euthyroidism as controls. Violent or absent fathers were significantly more prevalent in patients with prolactinoma or acromegaly than in controls (P = 0.001 and P = 0.002, respectively) but not in patients with non-secreting adenoma or corticotrophinoma. Absent fathers in prolactinoma and acromegaly versus controls: P = 0.001 and P = 0.119. Violent fathers in prolactinoma and acromegaly versus controls: P = 0.069 and P = 0.001. The prevalence of absent or violent fathers was also significantly higher in prolactinoma and acromegaly when compared to non-secreting adenoma (P = 0.039 and P = 0.033, respectively). Paternal deprivation before adolescence may be a risk factor for prolactinoma and acromegaly but not for non-secreting pituitary adenomas or Cushing's disease.

Entities:  

Mesh:

Year:  2012        PMID: 21701822     DOI: 10.1007/s11102-011-0324-1

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  21 in total

Review 1.  Parental loss in childhood. Its effect in adult life.

Authors:  C Tennant
Journal:  Arch Gen Psychiatry       Date:  1988-11

2.  Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

Authors:  Kathryn G Schuff; Shane T Hentges; Michele A Kelly; Nadine Binart; Paul A Kelly; P Michael Iuvone; Sylvia L Asa; Malcolm J Low
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.

Authors:  José Leon-Carrion; Juan Francisco Martin-Rodriguez; Ainara Madrazo-Atutxa; Alfonso Soto-Moreno; Eva Venegas-Moreno; Elena Torres-Vela; Pedro Benito-López; Maria Angeles Gálvez; Francisco J Tinahones; Alfonso Leal-Cerro
Journal:  J Clin Endocrinol Metab       Date:  2010-06-16       Impact factor: 5.958

4.  Life events in the pathogenesis of hyperprolactinemia.

Authors:  N Sonino; C Navarrini; C Ruini; F Fallo; M Boscaro; G A Fava
Journal:  Eur J Endocrinol       Date:  2004-07       Impact factor: 6.664

Review 5.  Prolactin, psychological stress and environment in humans: adaptation and maladaptation.

Authors:  Luis Gonçalves Sobrinho
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

6.  Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state.

Authors:  L G Sobrinho; M Simões; L Barbosa; J F Raposo; S Pratas; P L Fernandes; M A Santos
Journal:  Psychoneuroendocrinology       Date:  2003-01       Impact factor: 4.905

7.  Psychosocial aspects of hyperprolactinemia.

Authors:  J Assies; A J Vingerhoets; K Poppelaars
Journal:  Psychoneuroendocrinology       Date:  1992-11       Impact factor: 4.905

8.  Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene.

Authors:  K E Mayo; R E Hammer; L W Swanson; R L Brinster; M G Rosenfeld; R M Evans
Journal:  Mol Endocrinol       Date:  1988-07

Review 9.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

Authors:  T Sano; S L Asa; K Kovacs
Journal:  Endocr Rev       Date:  1988-08       Impact factor: 19.871

10.  Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea.

Authors:  M C Nunes; L G Sobrinho; C Calhaz-Jorge; M A Santos; J C Mauricio; M F Sousa
Journal:  Obstet Gynecol       Date:  1980-05       Impact factor: 7.661

View more
  2 in total

1.  Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example.

Authors:  Katherine E King; Jennifer B Kane; Peter Scarbrough; Cathrine Hoyo; Susan K Murphy
Journal:  Biodemography Soc Biol       Date:  2016

Review 2.  Prolactin and human weight disturbances: A puzzling and neglected association.

Authors:  Luis G Sobrinho; Nelson D Horseman
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.